
Birya Biotech develops a technique to refill autoinjectors, aiming to extend device usability and reduce single-use waste. The company is a medical device/biotech startup working on a patent-pending refill method for autoinjectors, positioning it as a B2B technology for device manufacturers, healthcare providers, and pharmaceutical companies. The approach focuses on a refill mechanism compatible with existing autoinjector designs rather than drug formulation, and is intended for integration into injectable drug-delivery workflows. The technology targets the large market for injectable therapies by enabling reusable delivery systems and reducing disposal and device replacement needs.

Birya Biotech develops a technique to refill autoinjectors, aiming to extend device usability and reduce single-use waste. The company is a medical device/biotech startup working on a patent-pending refill method for autoinjectors, positioning it as a B2B technology for device manufacturers, healthcare providers, and pharmaceutical companies. The approach focuses on a refill mechanism compatible with existing autoinjector designs rather than drug formulation, and is intended for integration into injectable drug-delivery workflows. The technology targets the large market for injectable therapies by enabling reusable delivery systems and reducing disposal and device replacement needs.
Core product: Patent-pending refill technique for autoinjectors (medical device/biotech)
Customers: B2B: device manufacturers, healthcare providers, pharmaceutical companies
Founded: 2017
Industry: Biotechnology
Single-use waste from autoinjectors and the cost/inefficiency of disposable injectable delivery devices.
2017
Biotechnology
Investors listed in evidence: MedStartr Ventures, VentureOut (presence indicated in company snapshot)